Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionPERRY, D. J; HARPER, P. L; FAIRHAM, S et al.FEBS letters. 1989, Vol 254, Num 1-2, pp 174-176, issn 0014-5793, 3 p.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

Antithrombin III and arterial diseaseCORTELLARO, M.Lancet (British edition). 1991, Num 8781, pp 1525-1526, issn 0140-6736Article

The physiologic role of antithrombin III as an anticoagulant. DiscussionPIZZO, S. V; CINES; FAREED et al.Seminars in hematology. 1994, Vol 31, Num 2, pp 4-9, issn 0037-1963, SUP1Conference Paper

Les nouvelles héparines = New heparinsDJIANE, P.Méditerranée médicale. 1986, Num 357, pp 21-23, issn 0302-9263Article

Functional determination of antithrombin III in clinical samples and therapeutic concentratesJAWED FAREED; WALENGA, J. M; SVENDSEN, L. G et al.Seminars in thrombosis and hemostasis. 1986, Vol 12, Num 4, pp 328-334, issn 0094-6176Article

Thrombin generation and inactivation in the presence of antithrombin III and heparinLINDHOUT, T; BARUCH, D; SCHOEN, P et al.Biochemistry (Easton). 1986, Vol 25, Num 20, pp 5962-5969, issn 0006-2960Article

Manufacturing process for antithrombin III concentrate: Viral validation studies and effects of column re-use on viral safetyFALBO, A.Developments in biologicals. 2003, Vol 113, pp 81-88, issn 1424-6074, 8 p.Conference Paper

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinLANE, D. A; FLYNN, A; IRELAND, H et al.British journal of haematology. 1987, Vol 65, Num 4, pp 451-456, issn 0007-1048Article

Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of α-thrombinOLSON, S. T.The Journal of biological chemistry (Print). 1985, Vol 260, Num 18, pp 10153-10160, issn 0021-9258Article

Humanplasmafraktion Antithrombin IIIDORNHEIM, G.Pharmazie. 1988, Vol 43, Num 1, issn 0031-7144, 55Article

Antithromtin-III-Hamilton, Ala 382 to Thr : an antithrombin-III variant that acts as a substrate but not an inhibitor of α-thrombin and factor XaAUSTIN, R. C; RACHUBINSKI, R. A; OFOSU, F. A et al.Blood. 1991, Vol 77, Num 10, pp 2185-2189, issn 0006-4971Conference Paper

Assessment of interference by heparin cofactor II in the DuPont aca^® antithrombin-III assayHORTIN, G. L; TOLLEFSEN, D. M; SANTORO, S. A et al.American journal of clinical pathology. 1988, Vol 89, Num 4, pp 515-517, issn 0002-9173Article

Antithrombin III (AT III) ― Eine Beobachtungsstudie an 304-Patienten mit bakteriellen Infektionen (sepsis) auf einer medizinischen Intensivstatien = Antithrombine III. Une étude d'observation sur 304 malades avec infections bactériennes (septicémie) en unité de soins intensifs = Antithrombin III. An observation study of 304 patients with bacterial infections (septicaemia) in a medical intersive care unitHEITZ, J. E; MAURER, A; ARNTZ, H.-R et al.Intensivmedizin + Notfallmedizin. 1988, Vol 25, Num 8, pp 385-392, issn 0175-3851Article

Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybreneOSHIMA, G.Thrombosis research. 1988, Vol 51, Num 6, pp 565-574, issn 0049-3848Article

Substitution of antithrombin III in shock and DIC: a randomized studyBLAUHUT, B; KRAMAR, H; VINAZZER, H et al.Thrombosis research. 1985, Vol 39, Num 1, pp 81-89, issn 0049-3848Article

Déficit en antithrombine III induit par l'héparine et déficit constitutionnel en protéine C: à propos d'un cas = Antithrombin III deficiency induced by heparin, and the constitutional deficiency in protein C: one caseVERGOZ, D; KANNAPEL, M. F; HIEAUX, C et al.Phlébologie. 1985, Vol 38, Num 3, pp 425-427, issn 0031-8280Article

High and low anticoagulant activity heparins: preparation in large scale and degree of complexation with antithrombin IIITAKAHASHI, H. K; NADER, H. B; DIETRICH, C. P et al.Arzneimittel-Forschung. 1985, Vol 35, Num 11, pp 1620-1623, issn 0004-4172Article

Antithrombin III and arterial diseaseMEAD, T. W; COOPER, J; MILLER, G. J et al.Lancet (British edition). 1991, Vol 338, Num 8771, pp 850-851, issn 0140-6736Article

Conformation of antithrombin III with defective biological functions derived from a thrombophilic patientURATANI, Y; MURAYAMA, H; MATSUDA, M et al.Thrombosis research. 1988, Vol 49, Num 6, pp 591-600, issn 0049-3848Article

Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, antithrombin III ToyamaSAKURAGAWA, N; KONDO, S; KATOH, M et al.Thrombosis research. 1987, Vol 47, Num 2, pp 147-153, issn 0049-3848Article

Case report: amelioration of antithrombin III deficiency by coumarin administrationKITCHENS, C. S.The American journal of the medical sciences. 1987, Vol 293, Num 6, pp 403-406, issn 0002-9629Article

Fully automated antithrombin-III assays by synthetic substrate on the multistat III^®BICK, R. L; WHEELER, A.American journal of clinical pathology. 1987, Vol 88, Num 2, pp 192-197, issn 0002-9173Article

Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin IIIBARUCH, D; FRANSSEN, J; COENRAAD HEMKER, H et al.Thrombosis research. 1985, Vol 38, Num 5, pp 447-458, issn 0049-3848Article

Antithrombin III regulates complement activity in vitroWEILER, J. M; LINHARDT, R. J.The Journal of immunology (1950). 1991, Vol 146, Num 11, pp 3889-3894, issn 0022-1767, 6 p.Article